MedTrace Logo

Prospective Observational Study to Evaluate the Safety of Immunotherapy as a Treatment for Hymenoptera Venom Allergy

NCT06782217 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2025-05-04

No results posted yet for this study

Summary

Observational study to evaluate the safety of immunotherapy as a treatment for Hymenoptera venom allergy, analyzing the adverse reaction to immunotherapy as well as the allergic reaction to a spontaneous hymenoptera sting. This study will be conducted in Spain (multicentric) and data will be collected prospectively.

Conditions

  • Allergy, Insect Venom
  • Allergy Insect Stinging
  • Insect Sting Allergy

Interventions

BIOLOGICAL

VENOX

Treatment with allergy vaccine againts Vespula spp. (wasp) or Apis mellifera (bee), as per clinical indication.

Sponsors & Collaborators

  • Inmunotek S.L.

    lead INDUSTRY

Principal Investigators

  • Francisco Javier Carballada, MD · Hospital Universitario Lucus Augusti

Eligibility

Min Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-01
Primary Completion
2026-11-01
Completion
2027-02-01

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06782217 on ClinicalTrials.gov